Overview of Basic Immunology and Clinical Application

被引:7
作者
Stephen, Bettzy [1 ]
Hajjar, Joud [2 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Houston, TX 77030 USA
来源
IMMUNOTHERAPY, 3RD EDITION | 2020年 / 1244卷
关键词
Adaptive; Biomarkers; Checkpoint inhibitors; Immune cells; Immune checkpoints; Immunology; Immunotherapy; Innate; Resistance; Response; T cells; Translational; TUMOR-ASSOCIATED MACROPHAGES; REGULATORY T-CELLS; ADVANCED MELANOMA PATIENTS; BREAST-CANCER CELLS; MAST-CELLS; PD-1; BLOCKADE; SIGNALING PATHWAYS; PERIPHERAL-BLOOD; INNATE IMMUNITY; IFN-GAMMA;
D O I
10.1007/978-3-030-41008-7_1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor exists as a complex network of structures with an ability to evolve and evade the host immune surveillance mechanism. The immune milieu which includes macrophages, dendritic cells, natural killer cells, neutrophils, mast cells, B cells, and T cells are found in the core, the invasive margin, or the adjacent stromal or lymphoid component of the tumor. The immune infiltrate is heterogeneous and varies within a patient and between patients of the same tumor histology. The location, density, functionality, and cross-talk between the immune cells in the tumor microenvironment influence the nature of immune response, prognosis, and treatment outcomes in cancer patients. Therefore, an understanding of the characteristics of the immune cells and their role in tumor immune surveillance is of paramount importance to identify immune targets and to develop novel immune therapeutics in the war against cancer. In this chapter, we provide an overview of the individual components of the human immune system and the translational relevance of predictive biomarkers.
引用
收藏
页码:1 / 36
页数:36
相关论文
共 280 条
[1]   A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis [J].
Acharyya, Swarnali ;
Oskarsson, Thordur ;
Vanharanta, Sakari ;
Malladi, Srinivas ;
Kim, Juliet ;
Morris, Patrick G. ;
Manova-Todorova, Katia ;
Leversha, Margaret ;
Hogg, Nancy ;
Seshan, Venkatraman E. ;
Norton, Larry ;
Brogi, Edi ;
Massague, Joan .
CELL, 2012, 150 (01) :165-178
[2]   NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity [J].
Albertsson, PA ;
Basse, PH ;
Hokland, M ;
Goldfarb, RH ;
Nagelkerke, JF ;
Nannmark, U ;
Kuppen, PJK .
TRENDS IN IMMUNOLOGY, 2003, 24 (11) :603-609
[3]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[4]   Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation [J].
Anderson, Ana C. ;
Joller, Nicole ;
Kuchroo, Vijay K. .
IMMUNITY, 2016, 44 (05) :989-1004
[5]  
[Anonymous], 2015, J CLIN ONCOL S
[6]  
[Anonymous], FDA APPR KEYTR ADV N
[7]   Rationale for anti-OX40 cancer immunotherapy [J].
Aspeslagh, Sandrine ;
Postel-Vinay, Sophie ;
Rusakiewicz, Sylvie ;
Soria, Jean-Charles ;
Zitvogel, Laurence ;
Marabelle, Aurelien .
EUROPEAN JOURNAL OF CANCER, 2016, 52 :50-66
[8]  
Ayers M, 2015, J IMMUNOTHER CANCER, V3, P80, DOI DOI 10.1186/2051-1426-3-S2-P80
[9]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[10]   Natural killer cells in innate immunity and cancer [J].
Becknell, Brian ;
Caligiuri, Michael A. .
JOURNAL OF IMMUNOTHERAPY, 2008, 31 (08) :685-692